Placenta tipo jelly like y desenlaces materno perinatales en una institución de 4 nivel de Bogotá 2019-2021

dc.contributorGonzález Pinto, Ricardo Arturo
dc.contributorBuitrago-Medina, Daniel-Alejandro
dc.creatorRodríguez Borda, Guillermo Federico
dc.date.accessioned2022-08-09T16:41:29Z
dc.date.accessioned2022-09-22T14:58:27Z
dc.date.available2022-08-09T16:41:29Z
dc.date.available2022-09-22T14:58:27Z
dc.date.created2022-08-09T16:41:29Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/34681
dc.identifierhttps://doi.org/10.48713/10336_34681
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3443868
dc.description.abstractIntroduction: The ischemic placental disease composed of preeclampsia, FGR and placental abruption lead to important maternal and neonatal mortality and morbidity. For that reason, diagnostic tools and sonographic predictors to diagnosis these entities are a must to apply an early diagnosis and treatment. Jelly like placenta is an uncommon sonographic finding related with adverse maternal and neonatal outcomes. Methodology: Descriptive study type of case series with patients of perinatology service of Centro Policlinico del Olaya. Those ultrasound studies showed a jelly like placenta. A follow up of the pregnancy was done and the maternal and neonatal outcomes were assesed. Outcome: 50 patients were taken as a sample for the study, from July 19 th to July 21th.The 16% of neonates show low weight, the 26% of patients got hypertensive disorders in pregnancy. None of the newborns presented genetic alterations The newborn mortality was 2% due to placental abruption. Conclusion: The Jelly like placenta is a not well known untrasound finding. There are very few descriptive cases about it.Neverhteless, this finding can be related to hypertensitive disorders in pregnancy, such as fetal growth restrictions. Early diagnosis allows close follow up for the diagnosis of the ischemic placental disease and thereby reduce maternal and neonatal mortality and morbidity.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Ginecología y Obstericia
dc.publisherEscuela de Medicina y Ciencias de la Salud
dc.rightshttp://creativecommons.org/licenses/by-sa/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.rightsAtribución-CompartirIgual 2.5 Colombia
dc.sourceBOGOTÁ SDDS DE. Mortalidad materna. Available from: http://www.saludcapital.gov.co/sitios/VigilanciaSaludPublica/Protocolos de Vigilancia en Salud Publica/Mortalidad Materna.pdf
dc.sourceAnanth C V, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195:1557–63.
dc.sourceAnanth C. Ischemic placental disease: A unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol. 2014;38(3):131–2.
dc.sourceSay L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Articles Global causes of maternal death: a WHO systematic analysis. Lancet Glob Heal. 2014;6(2):323–33.
dc.sourceColombia I nacional de S de. Boletín epidemiológico semanal: semana 9. 2020. Available from: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2020_Boletin_epidemiologico_semana_9.pdf
dc.sourceNICE. Hypertension in pregnancy: diagnosis and management. 2019. Available from: www.nice.org.uk/guidance/ng133
dc.sourceTan MY, Syngelaki A, Poon LC, Rolnik DL, O’Gorman N, Delgado JL, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2018 Aug 1;52(2):186–95.
dc.sourceRolnik D, Wright D, Poon L, O´Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017;377:613–22.
dc.sourceTownsend R, Khalil A, Premakumar Y, Allotey J, Snell KIE, Chan C, et al. Prediction of pre-eclampsia: review of reviews. Ultrasound Obstet Gynecol. 2019 Jul 1;54(1):16–27.
dc.sourceRoberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014;38(3):139–45.
dc.sourceFriedman AM, Cleary KL. Prediction and prevention of ischemic placental disease. Semin Perinatol. 2014 Apr;38(3):177–82.
dc.sourcePredoi CG, Grigoriu C, Vladescu R, Mihart AE. Placental damages in preeclampsia-from ultrasound images to histopathological findings. J Med Life. 2015;8:62–5.
dc.sourceKingdom JC, Audette MC, Hobson SR, Windrim RC, Morgen E. A placenta clinic approach to the diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2):803–17.
dc.sourceShinde G, Vaswani B, Patange R, Laddad M, Bhosale R. Diagnostic Performance of Ultrasonography for Detection of Abruption and Its Clinical Correlation and Maternal and Foetal Outcome. J Clin diagnostical Res. 2016;10(8):4–7.
dc.sourceBurton GJ, Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. Am J Obstet Gynecol. 2018;2(s):745–61.
dc.sourceVintzileos AM, Ananth C V. First trimester prediction of ischemic placental disease. Semin Perinatol. 2014;38(3):159–66.
dc.sourceSavasan ZA, Goncalves LF, Bahado-Singh RO. Second-and third-trimester biochemical and ultrasound markers predictive of ischemic placental disease. Semin Perinatol. 2014;38(3):167–76.
dc.sourceJoško O, Kristina K. Clinical, Biochemical, and Biophysical Markers of Angiogenesis in Preeclampsia. Predict Matern Fetal Syndr Preeclampsia. 2019 May 23
dc.sourcePoon LC, Wright D, Rolnik DL, Syngelaki A, Luis Delgado J, Tsokaki T, et al. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217(5):1–5.
dc.sourceChaemsaithong P, Daljit ;, Sahota S, Liona ;, Poon C. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2020;226:1071–97.
dc.sourceStoenescu M, Serbanescu M-S, Dijmarescu Al, Manolea Mm, Novac L, Tudor A, et al. Doppler Uterine Artery Ultrasound in the Second Trimester of Pregnancy to Predict Adverse Pregnancy Outcomes. Curr Heal Sci J. 2021;47(1):106.
dc.sourceVentura W, De Paco Matallana C, Prieto-Sanchez MT, Macizo MI, Pertegal M, Nieto A, et al. Uterine and umbilical artery Doppler at 28 weeks for predicting adverse pregnancy outcomes in women with abnormal uterine artery Doppler findings in the early second trimester. Prenat Diagn. 2015;35(3):294–8.
dc.sourceValiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH, Akolekar DR. Biophysical and biochemical markers at 30-34 weeks’ gestation in the prediction of adverse perinatal outcome. Ultrasound Obs Gynecol. 2016;47:194–202.
dc.sourceFadl S, Moshiri M, Fligner CL, Katz DS, Dighe M. Placental Imaging: Normal Appearance with Review of Pathologic Findings . RadioGraphics. 2017;37:979–98.
dc.sourceZaidi SF, Moshiri M, Osman S, Robinson TJ, Siebert JR, Bhargava P, et al. Comprehensive imaging review of abnormalities of the placenta. Vol. 32, Ultrasound Quarterly. Lippincott Williams and Wilkins; 2016. p. 25–42.
dc.sourceMoran M, Mcauliffe FM. Imaging and assessment of placental function. Vol. 39, Journal of Clinical Ultrasound. 2011:390–8.
dc.sourceAbramowicz JS, Sheiner E. Ultrasound of the Placenta: A Systematic Approach. Part I: Imaging. Placenta. 2008;29(3):225–40.
dc.sourceMasliza Wan Daud W, Yazid Bajuri M, Rohaizat Hassan M, Mohd Naim N, Ahmad S, Das S, et al. Sonographically abnormal placenta: an association with an increased risk poor pregnancy outcomes. Clin Ter. 2017;168(5):283–9.
dc.sourceRheinboldt M, Delproposto Z. Sonography of placental abnormalities: a pictorial review. Vol. 22, Emergency Radiology. Springer New York LLC; 2015: 401–8.
dc.sourceGudmundsson S, Dubiel M, Sladkevicius P. Placental Morphologic and Functional Imaging in High-Risk Pregnancies. Vol. 33, Seminars in Perinatology. 2009. p. 270–80.
dc.sourceBowman ZS, Kennedy AM. Sonographic Appearance of the Placenta. Curr Probl Diagn Radiol. 2014;43(6):356–73.
dc.sourceNguyen D, Nguyen C, Yacobozzi M, Bsat F, Rakita D. Imaging of the Placenta with Pathologic Correlation. Semin Ultrasound, CT MRI. 2012 Feb;33(1):65–77.
dc.sourceJauniaux E, Ramsay B, Campbell S. Ultrasonographic investigation of placental morphologic characteristics and size during the second trimester of pregnancy. Am J Obstet Gynecol. 1994;170(1):130–7.
dc.sourceHata T, Tanaka H, Noguchi J, Hata K. Three-dimensional ultrasound evaluation of the placenta. Placenta. 2011;32(2):105–15.
dc.sourceJauniaux E, Moscoso G, Campbell S, Gibb D, Driver M, Nicolaides KH. Correlation of ultrasound and pathologic findings of placental anomalies in pregnancies with elevated maternal serum at-fetoprotein. Eur J Obstet Gynecol Reprod Biol. 1990;37(3):219–30.
dc.sourceWeston M. Disorders of the Placenta: Localization and Placental Attachment Disorders. In: Twining’s Textbook of Fetal Abnormalities. 3rd ed. London: Churchill Livingstone; 2015.
dc.sourceSebire NJ, Sepulveda W. Correlation of placental pathology with prenatal ultrasound findings. J Clin Pathol. 2008;61(12):1276–84.
dc.sourceRaio L, Ghezzi F, Cromi A, Nelle M, Dürig P, Schneider H. The thick heterogeneous(jellylike) placenta: a strong predictor of adverse pregnancy outcome. Prenat Diagn. 2004 Mar 1;24(3):182–8.
dc.sourceVogt M, Thomas A, Kalache K. Increase of Pregnancy Complications by Detection of the `Jelly- Like’ Placenta. Ultrasound Med Biol. 2011;37(8):s122.
dc.sourceRaio L, Ghezzi F, Di Naro E, McDougall F, Cromi A, Meyer C, et al. P210: Sonographic ‘jelly like’ placenta and pregnancy outcome. Obstet Gynecol. 2003;22(S1):126–7.
dc.sourceresidentes de Medicina Familiar y Comunitaria en la, localidad de Capilla del Sauce. PREVALENCIA DE PARASITOSIS INTESTINALES EN POBLACIÓN INFANTIL DE CAPILLA DEL SAUCE (DEPARTAMENTO DE FLORIDA). Available from: https://www.smu.org.uy/cartelera/socio-cultural/prevalen.pdf
dc.sourceSmart E, Armstrong B. Blood group systems. ISBT Sci Ser. 2008;3(2):68–92.
dc.sourceFlores Sandí G. Personal pathological patológico en la anamnesis information in the Clinical History. Rev Costarr Salud Pública. 2014;24(1):49–53.
dc.sourceBattarbee A, Sinkey RG, Harper LM, Oparil S, Tita A. Chronic Hypertension in Pregnancy. Am J Obstet Gynecol. 2020;222(6):532–41.
dc.sourceLowe S, Bowyer L, Lust K, McMahon L, Morton M, North R, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy. Aust New Zeal J Obstet Gynaecol. 2015;55(5):1–29.
dc.sourceTranquilli A, Dekker G, Magee L, Roberts J, Sibai B, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 214AD;4(2):97–104.
dc.sourceBaz B, Riveline J-P, Gautier J-F. Gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol. 2016;174(2):43–51.
dc.sourceKerner W, Brückel J. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol diabetes. 2014;122(07):384–6.
dc.sourceAssociation. AD. Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):14–31.
dc.sourceFava A, Petri M. Systemic Lupus Erythematosus: Diagnosis and Clinical Management. J Autoimmun. 2019;96:1–13.
dc.sourceCorban, M. T., Duarte-Garcia A, McBane RD, Matteson EL, Lerman LO, Lerman A. Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J Am Coll Cardiol. 2017;69(18):2317–30.
dc.sourceChaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390:1550–62.
dc.sourceDevereaux D, Tewelde SZ. Hyperthyroidism and Thyrotoxicosis. Emerg Med Clin North Am. 2014;32(2):277–92.
dc.sourceCancino E, León H, Otálora R, Pérez E, Sarmiento R, Yates A. Guía de control prenatal y factores de riesgo. Bogotá; 2004.
dc.sourceRouse, C. E., Eckert LO, Babarinsa I, Fay E, Gupta M, Harrison, M. S. et al. Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2017;35:6563–74.
dc.sourceSociedad española de medicina de familia y comunitaria. GUÍA PRÁCTICA DE LA SALUD. 2005 Nov. Available in: https://www.semfyc.es/pacientes/cuidarse/guia-practica-de-la-salud/
dc.sourceGómez M, Danglot C, Gómez M. Clasificación de los niños recién nacidos. Rev Mex pediatría. 2012 Jan;79(1):32–9.
dc.sourceCarvajal J, Ralph C. 33 Semiología obstétrica. In: Manual ginecología y obstetricia. VIII. Santiago: Universidad Católica de Chile; 2017. p. 317–21.
dc.sourceACOG. Practice Bulletin No. 171: Management of Preterm Labor. Vol. 128, Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2016. p. e155–64.
dc.sourceElizalde V, Calderón A, García A, Díaz M. Abruptio placentae: morbimortalidad y resultados perinatales. Med e Investig. 2015;3(2):109–15.
dc.sourceBraunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Med. 2019;7:1–15.
dc.sourceSchlaudecker EP, Munoz FM, Bardají A, Boghossian NS, Khalil A, Mousa H, et al. Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine. 2017;35:6518–28.
dc.sourceOrr B, Godek KM, Compton D, Edu DAC. Aneuploidy. Curr Biol. 2015;25(13):538–42.
dc.sourceRamírez J. Anomalías fetales. Available from: https://www.uv.es/~jvramire/apuntes/passats/obstetricia/TEMA O-16.pdf
dc.sourceRezaie Keikhaie K, Kazemi Z, Moshfeghi M, Nakhaee Moghaddam M. Prevalence of Intrauterine Fetal Death in Iran: A Meta-Analysis and Systematic Review. Ann Med Heal Sci Res. 2018;8:275–8.
dc.sourceMaternidad Segura E, Rozo Gutiérrez Equipo Maternidad Segura N, Lucía Ospina Martínez M, Edwin Prieto Alvarado F, Eduardo Pacheco García Ó, Quijada Bonilla H. MORTALIDAD PERINATAL Y NEONATAL TARDÍA. Bogotá; 2017. Available from: https://www.ins.gov.co/buscador-eventos/Lineamientos/PRO Mortalidad perinatal neonatal.pdf
dc.sourceKeshavarz E, Motevasselian M, Amirnazeri B, Bahramzadeh S, Mohammadkhani H, Mehrjardi Z, et al. Gestational age-specific reference values of placental thickness in normal pregnant women. Women Health. 2019;59(7):718–29.
dc.sourceACOG. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020 Jun 1;135(6):e237–60.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectPlacenta jelly like
dc.subjectPreeclampsia
dc.subjectRCIU
dc.subjectAbrupcio de placenta
dc.subjectEnfermedad isquémica placentaria
dc.titlePlacenta tipo jelly like y desenlaces materno perinatales en una institución de 4 nivel de Bogotá 2019-2021
dc.typebachelorThesis


Este ítem pertenece a la siguiente institución